Treatment of rosacea

Details Treatment of rosacea Treatment of rosacea

2006-09-12

2006-09-12

Padmanabhan, Sreeni (Department: 1616)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

C424S450000, C424S451000, C424S464000, C424S078050, C514S381000

Reexamination Certificate

active

07105172

ABSTRACT:
Disclosed herein are methods for the treatment or prevention of rosacea in a patient, including administering a compound that inhibits one or more components of the bradykinin activation pathway in an amount sufficient to reduce or prevent one or more symptoms of rosacea.

REFERENCES:
patent: 4944949 (1990-07-01), Story et al.
patent: 4954487 (1990-09-01), Cooper et al.
patent: 5212182 (1993-05-01), Musser et al.
patent: 5409899 (1995-04-01), Fauchere et al.
patent: 5416191 (1995-05-01), Cheronis et al.
patent: 5464820 (1995-11-01), Burton et al.
patent: 5563162 (1996-10-01), Oku et al.
patent: 5569651 (1996-10-01), Garrison et al.
patent: 5574042 (1996-11-01), Oku et al.
patent: 5597803 (1997-01-01), Breipohl et al.
patent: 5610140 (1997-03-01), Goodfellow et al.
patent: 5620958 (1997-04-01), Cheronis et al.
patent: 5635593 (1997-06-01), Cheronis et al.
patent: 5700779 (1997-12-01), Goodfellow et al.
patent: 5741794 (1998-04-01), Bowles et al.
patent: 5750506 (1998-05-01), Goodfellow et al.
patent: 5750699 (1998-05-01), Oku et al.
patent: 5795574 (1998-08-01), Breton et al.
patent: 5834431 (1998-11-01), Stewart et al.
patent: 5837270 (1998-11-01), Burgess
patent: 5843900 (1998-12-01), Cheronis et al.
patent: 5849312 (1998-12-01), Breton et al.
patent: 5849863 (1998-12-01), Stewart et al.
patent: 5863899 (1999-01-01), Cheronis et al.
patent: 5897880 (1999-04-01), Drizen et al.
patent: 5968951 (1999-10-01), Dodey et al.
patent: 5972993 (1999-10-01), Ptchelintsev
patent: 6017932 (2000-01-01), Singh et al.
patent: 6057347 (2000-05-01), Garvey et al.
patent: 6060061 (2000-05-01), Breton et al.
patent: 6071955 (2000-06-01), Elias et al.
patent: 6080758 (2000-06-01), Dodey et al.
patent: 6150403 (2000-11-01), Biedermann et al.
patent: 6174878 (2001-01-01), Gamache et al.
patent: 2003/0191098 (2003-10-01), D'Amato
patent: 660809 (1993-12-01), None
patent: 0 548 825 (1993-06-01), None
patent: 0 552 106 (1993-07-01), None
patent: 0 564 972 (1993-10-01), None
patent: 0 578 521 (1994-01-01), None
patent: 0 596 406 (1994-05-01), None
patent: 0 622 361 (1994-11-01), None
patent: 2768622 (2002-01-01), None
patent: WO 93/11789 (1993-06-01), None
patent: WO 96/13485 (1996-05-01), None
patent: WO 96/40639 (1996-12-01), None
patent: WO 97/07115 (1997-02-01), None
patent: WO 97/11069 (1997-03-01), None
Guarrera et al, Flushing in Rosacea: A Possible Mechanism, Archives Dermatologicla Research, 1982; 272 (3-4):311-6.
Bhoola et al., “Bioregulation of Kinins: Kallikreins, Kininogens, and Kininases,”Pharmacological Reviews, 44:1-80 (1992).
Fisher et al., “Cellular, Immunologic and Biochemical Characterization of Topical Retinoic Acid-Treated Human Skin,”J. Invest. Dermatol., 96:699-707 (1991).
Regoli et al., “Pharmacology of Bradykinin and Related Kinins,”Pharmacological Reviews, 32:1-46 (1980).
Siragy et al., “Protective Role of the Angiotensin AT2Receptor in a Renal Wrap Hypertension Model,” 33:1237-1242 (1999).
Starr et al., “Bradykinin and Oedema Formation in Heated Paws of Rats,”Br. J. Pharmac. Chemother., 31:178-187 (1967).
Guarrera et al., “Flushing In Rosacea: A Possible Mechanism,”Arch. Dermatol. Res.272:311-316 (1982).
Juhlin, “Late-phase Cutaneous Reactions To Platelet Activating Factor And Kallikrein In Urticaria,”Clinical and Experimental Allergy, Supplemental 4, 90:9-10 (1990).
Michaëlsson, “Effects of Antihistamines, Acetylsalicylic Acid and Prednisone on Cutaneous Reactions to Kallikrein and Prostaglandin E1,”Acta Dermatovener50:31-36 (1970).
Starr et al., “Oculocutaneous Aspects of Rosacea,”Proc. roy. Soc. Med.62:9-11 (1969).
Thomas et al., “Prostaglandins, Kinin and Inflammation In the Rat,”Br. J. Pharmac.50:231-235 (1974).

Affiliated with

Also associated with

Rating

Treatment of rosacea does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of rosacea, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of rosacea will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3616357